03 Feb Date February 3, 2020 Categories News A phase II study in patients with Alzheimer’s and Parkinson’s Diseases has been initiated ScandiBio Therapeutics has initiated a Phase II study in patients with Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) u...
